Author:
De Vita F,Orditura M,Matano E,Bianco R,Carlomagno C,Infusino S,Damiano V,Simeone E,Diadema M R,Lieto E,Castellano P,Pepe S,De Placido S,Galizia G,Di Martino N,Ciardiello F,Catalano G,Bianco A R
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Al-Batran SE, Atmaka A, Hegewisc-Becker S, Jaeger D, Hahnfeld S, Rummel MJ, Seipelt G, Rost A, Orth J, Knuth A, Jaeger E (2004) Phase II trial of biweekly infusional fluorouracil, folinic acid and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol 22: 658–663
2. Alberts SR, Cervantes A, Van de Velde CJH (2003) Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14(Suppl 2): ii31–ii36
3. Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsagavej C (2002) Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma. Oncology 16: 16–18
4. Becouarn Y, Agostini C, Trufflandier N, Boulanger V (2001) Oxaliplatin: available data in non-colorectal gastrointestinal malignancies. Crit Rev Oncol Hematol 40: 265–272
5. Blot WJ, Devesa SS, Kneller RW, Fraumeni Jr JR (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287–1289
Cited by
157 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献